Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167

Watchlist Manager
Jacobio Pharmaceuticals Group Co Ltd Logo
Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
Watchlist
Price: 1.54 HKD Market Closed
Market Cap: 1.2B HKD
Have any thoughts about
Jacobio Pharmaceuticals Group Co Ltd?
Write Note

Relative Value

The Relative Value of one Jacobio Pharmaceuticals Group Co Ltd stock under the Base Case scenario is 0.89 HKD. Compared to the current market price of 1.54 HKD, Jacobio Pharmaceuticals Group Co Ltd is Overvalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
0.89 HKD
Overvaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
10
vs Industry
32
Median 3Y
34.2
Median 5Y
30.4
Industry
7.7
Forward
5.6
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-9.5
Industry
22.7
Forward
-8.8
vs History
vs Industry
Median 3Y
-8.7
Median 5Y
-6.6
Industry
21.6
vs History
vs Industry
Median 3Y
-8.6
Median 5Y
-6.5
Industry
25.2
vs History
85
vs Industry
57
Median 3Y
2.4
Median 5Y
2.8
Industry
2.5
vs History
65
vs Industry
55
Median 3Y
19.1
Median 5Y
19.2
Industry
7.7
Forward
1.3
vs History
12
vs Industry
9
Median 3Y
270.1
Median 5Y
225.9
Industry
9
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-3
Industry
4.2
Forward
-1.4
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-3
Industry
4.1
Forward
-1.4
vs History
vs Industry
Median 3Y
-5.9
Median 5Y
-3.8
Industry
5.7
vs History
vs Industry
Median 3Y
-5.3
Median 5Y
-3.4
Industry
3.6
vs History
85
vs Industry
54
Median 3Y
14.9
Median 5Y
19.6
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Jacobio Pharmaceuticals Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
1.2B HKD 48.9 -3.1 -0.7 -0.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 984 068.5 -180 532.6 -219 224.1 -216 722.5
US
Abbvie Inc
NYSE:ABBV
316.8B USD 5.7 62.5 15.5 23.8
US
Amgen Inc
NASDAQ:AMGN
145.1B USD 4.5 34.4 16.3 31
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119B USD 11.2 -248.1 24.7 26
US
Gilead Sciences Inc
NASDAQ:GILD
113.2B USD 4 902 10 10
US
Epizyme Inc
F:EPE
94.1B EUR 1 854.7 -473.3 -515.4 -501.6
AU
CSL Ltd
ASX:CSL
135.4B AUD 6 33.3 20.6 25.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.7B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.8 -58.9 -53.1
NL
argenx SE
XBRU:ARGX
34.3B EUR 18.4 -129.4 -104.1 -75.8
P/E Multiple
Earnings Growth
CN
Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
Average P/E: 210
Negative Multiple: -3.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 532.6 N/A
US
Abbvie Inc
NYSE:ABBV
62.5
412%
US
Amgen Inc
NASDAQ:AMGN
34.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -248.1
42%
US
Gilead Sciences Inc
NASDAQ:GILD
902
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -473.3 N/A
AU
CSL Ltd
ASX:CSL
33.3
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.8 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.4 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
Average EV/EBITDA: 17.2
Negative Multiple: -0.7
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 224.1 N/A
US
Abbvie Inc
NYSE:ABBV
15.5
29%
US
Amgen Inc
NASDAQ:AMGN
16.3
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.7
43%
US
Gilead Sciences Inc
NASDAQ:GILD
10
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -515.4 N/A
AU
CSL Ltd
ASX:CSL
20.6
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.1 N/A
EV/EBIT Multiple
EBIT Growth
CN
Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
Average EV/EBIT: 22.4
Negative Multiple: -0.7
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 722.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.8
88%
US
Amgen Inc
NASDAQ:AMGN
31
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.6 N/A
AU
CSL Ltd
ASX:CSL
25.6
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.1 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -75.8 N/A

See Also

Discover More
Back to Top